MaxCyte, Inc. (NasdaqGS: MXCT)
Health Care · Life Sciences Tools & Services · US
$1.02
-4.67% today · -37.4% 1Y
MaxCyte, Inc. (NasdaqGS: MXCT) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $110.43M and employs 91 people.
Over the last twelve months the share price has lost 37.4%, trading between 0.64 and 1.87.
Tweenvest scores MaxCyte, Inc. across four factors: quality 51/100, value 53/100, growth 0/100. Its strongest factor is value.
MXCT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $110.43M
- Revenue (TTM)
- $31.05M
- P/E
- —
- EPS
- -0.33
- Dividend yield
- —
- Beta (5Y)
- 1.49
- 52-week high
- $1.87
- 52-week low
- $0.64
- Avg volume (3M)
- —
- Shares outstanding
- 103.21M
- Employees
- 91
- Next earnings
- —
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
- ISIN
- US57777K1060
- Founded
- 1998
- Listed since
- Jul 29, 2021
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genovis AB (publ.)OM: GENO | $130.17M | Skr19.30 | -0.62% |
| NanoEntek, Inc.KOSDAQ: A039860 | $127.99M | ₩4,555.00 | +8.71% |
| Seer, Inc.NasdaqGS: SEER | $124.59M | $2.17 | -3.56% |
| Curiosis, Inc.KOSDAQ: A494120 | $110.47M | ₩9,750.00 | +19.34% |
| Borosil Scientific LimitedBSE: 544184 | $103.70M | Rs112.25 | -2.86% |
| Selvita S.A.WSE: SLV | $103.37M | zł21.90 | 0.00% |
| Eurofins-Cerep SAENXTPA: ALECR | $102.24M | €18,100.00 | +19.87% |
| Macrogen, Inc.KOSDAQ: A038290 | $101.35M | ₩12,590.00 | +4.14% |
Figures last refreshed Oct 4, 2026.